Eli Lilly's stock declined after its rival Novo Nordisk received U.S. approval for its obesity medication, impacting investor sentiment in the pharmaceutical sector.
U.S. President Donald Trump announced he has approved South Korea to build a nuclear-powered submarine, marking a significant shift in regional security dynamics, with Seoul also seeking permission for nuclear fuel reprocessing, raising questions about proliferation and U.S.-South Korea relations.
Ukrainian President Zelenskyy announced that Ukraine now possesses domestically produced long-range weapons, allowing it to strike deep into Russia without needing US approval, marking a significant shift from previous reliance on Western systems and permissions.
A clinical study has found that the psychedelic drug MDMA, commonly known as ecstasy, can effectively alleviate symptoms of post-traumatic stress disorder (PTSD). The promising results pave the way for potential approval of MDMA as a treatment for PTSD in the United States.
The Netherlands and Denmark have received approval from the US to transfer F-16 fighter jets to Ukraine once pilot training is complete. The leaders of the international coalition supporting Ukraine's acquisition of the jets expressed gratitude for the US decision, but the timing of the transfers remains uncertain. The move is seen as a significant step for Ukraine's defense capabilities, and discussions with European partners are expected to follow. The coalition, led by Denmark and the Netherlands, aims to train Ukrainian pilots to fly F-16s starting in August.
Israel has received approval from the US Department of State to sell its Arrow 3 missile-defense system to Germany in a $3.5 billion deal, making it Israel's largest defense export ever. The Arrow 3 system, designed to intercept ballistic missiles outside Earth's atmosphere, is a co-development between the US Missile Defense Agency and Israel Aerospace Industries. The sale comes as Germany identifies Russia as its biggest security threat and aims to address the shortage of defense systems in Western nations. The deal is expected to boost Israeli defense exports, following last year's total of $12.5 billion.
Israel and Germany are in advanced negotiations for the sale of the Arrow 3 air defense system, jointly developed by Israel and the US. The deal is contingent on US approval. The Arrow 3 is part of Israel's multilayered air defense architecture and provides the upper tier for intercepting and countering exo-atmospheric ballistic missiles. The announcement follows the sale of David's Sling to Finland and Israel's recent sale of Spike missiles to Greece.